Title: Replication Code for: Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis
Type Dataset Ji, Yunan, Einav, Liran, Mahoney, Neale, Finkelstein, Amy (2022): Replication Code for: Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis. Harvard Dataverse. Dataset. https://dataverse.harvard.edu/dataset.xhtml?persistentId=doi:10.7910/DVN/NAXDC8
Links
- Item record in Abdul Latif Jameel Poverty Action Lab Dataverse
- Digital object URL
Summary
The replication package contains code to replicate tables and figures from "Financial Incentives to Facilities and Clinicians Treating Patients with End-Stage Kidney Disease and Use of Home Dialysis" by Ji, Einav, Mahoney, and Finkelstein (2022). Data is not included in this package as the data must be requested directly from Medicare. Please see the Readme file for additional details. The project evaluates the first year of the End Stage Renal Disease Treatment Choice (ETC) model, a multiyear, mandatory-participation randomized clinical trial of a payment reform, designed and implemented by the US Center for Medicare & Medicaid Innovation (CMMI). The trial found no statistically significantly different rates of home dialysis between treatment and control hospital referral regions during the first year of the program, suggesting that higher incentives may be necessary to change clinician and facility behavior.
More information
- DOI: 10.7910/DVN/NAXDC8
Subjects
- Medicine, Health and Life Sciences, Social Sciences, Health insurance, Medicare, payment reform, randomized controlled trial, field experiment, dialysis, home dialysis, kidney disease, end stage renal disease
Dates
- Publication date: 2022
- Submitted: November 21, 2022
- Updated: November 21, 2022
Rights
- info:eu-repo/semantics/openAccess
- http://creativecommons.org/publicdomain/zero/1.0 CC0 1.0
Format
electronic resource
Relateditems
Description | Item type | Relationship | Uri |
---|---|---|---|
IsCitedBy | https://doi.org/10.1001/jamahealthforum.2022.3503 |